Back to top
  • 공유 Share
  • 인쇄 Print
  • 글자크기 Font size
URL copied.

Blockchain healthcare startup Solve.Care partners with ridesharing giant Lyft

작성자 기본 이미지
Shampa Mani reporter

Mon, 04 Mar 2019, 10:07 am UTC

Image: Shutterstock

Estonian blockchain healthcare startup Solve.Care has entered into a partnership with on-demand rideshare service Lyft to improve public access to medical care.

Incorporated in 2017, Solve.Care uses blockchain technology for coordinating care, benefits and payments between patient, doctor, pharmacy, laboratory, employer, insurer, and all other parties. Its Care.Wallet application is available for download in 80+ countries on App Store and Google Play.

On Friday, Lyft filed IPO documents with the U.S. Securities and Exchange Commission (SEC) Friday, becoming the first app-based ride-hail company to go public, The Verge reported.

Through this first-of-its-kind integration of blockchain with ridesharing service, Solve.Care aims to provide a managed transportation solution that will offer patients and providers more options and greater control over non-emergency medical transportation.

According to the official release, Care.Wallet users would be able to schedule their own Lyft rides to doctors’ offices, hospitals, and pharmacies, with the ability to plug in desired arrival times. In addition, using their Care.Wallet, patients would be able to automatically make payment for the ride as well as share ride costs with their family members, employers, insurers and others.

The partnership also allows for coordination between patient, provider and family members, regarding assistance, arrival, cost and schedule adjustments.

“By partnering with Lyft, our platform will provide a more efficient and seamless experience for patients and enable payers, employers, and other agencies to improve patient satisfaction through timely access to care, reduced wait times, and simpler cost-sharing and access to transportation subsidies,” said Pradeep Goel, CEO of Solve.Care.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

Most Popular

Comment 0

0/1000

1